Ranbaxy, AstraZeneca Say Plaintiffs Lack Basis For New Trial
Ranbaxy Inc. and AstraZeneca PLC urged a Massachusetts federal court Monday to deny a bid by plaintiffs who lost a recent pay-for-delay class action trial over the heartburn drug Nexium to...To view the full article, register now.
Already a subscriber? Click here to view full article